Page last updated: 2024-09-02

ci 988 and tryptophan

ci 988 has been researched along with tryptophan in 3 studies

Compound Research Comparison

Studies (ci 988)	Trials (ci 988)	Recent Studies (post-2010) (ci 988)	Studies (tryptophan)	Trials (tryptophan)	Recent Studies (post-2010) (tryptophan)
147	8	14	32,762	936	7,183

Protein Interaction Comparison

Protein	Taxonomy	ci 988 (IC50)	tryptophan (IC50)
Myeloperoxidase	Homo sapiens (human)		2.25

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Birkemo, LS; Croom, DK; Dezube, M; Dougherty, RW; Ervin, GN; Grizzle, MK; James, MK; Johnson, MF; Mosher, JT; Sugg, EE	1
Horwell, D; Pritchard, M; Raphy, J; Ratcliffe, G	1
Hinton, JP; Trivedi, BK	1

Reviews

2 review(s) available for ci 988 and tryptophan

Article	Year
'Targeted' molecular diversity: design and development of non-peptide antagonists for cholecystokinin and tachykinin receptors. Immunopharmacology, 1996, Volume: 33, Issue:1-3 Topics: Amino Acid Sequence; Animals; Drug Design; Drug Evaluation, Preclinical; Hormone Antagonists; Humans; Indoles; Ligands; Meglumine; Molecular Structure; Oligopeptides; Peptide Library; Phenylalanine; Receptors, Cholecystokinin; Receptors, Tachykinin; Tryptophan	1996
CI-1015. An orally active CCK-B receptor antagonist with an improved pharmacokinetic profile. Pharmaceutical biotechnology, 1998, Volume: 11 Topics: Adamantane; Administration, Oral; Animals; Brain; Humans; Indoles; Meglumine; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Structure-Activity Relationship; Tryptophan	1998

Article

Year

'Targeted' molecular diversity: design and development of non-peptide antagonists for cholecystokinin and tachykinin receptors.

Immunopharmacology, 1996, Volume: 33, Issue:1-3

Topics: Amino Acid Sequence; Animals; Drug Design; Drug Evaluation, Preclinical; Hormone Antagonists; Humans; Indoles; Ligands; Meglumine; Molecular Structure; Oligopeptides; Peptide Library; Phenylalanine; Receptors, Cholecystokinin; Receptors, Tachykinin; Tryptophan

1996

CI-1015. An orally active CCK-B receptor antagonist with an improved pharmacokinetic profile.

Pharmaceutical biotechnology, 1998, Volume: 11

Topics: Adamantane; Administration, Oral; Animals; Brain; Humans; Indoles; Meglumine; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Structure-Activity Relationship; Tryptophan

1998

Other Studies

1 other study(ies) available for ci 988 and tryptophan

Article	Year
Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands. Journal of medicinal chemistry, 1995, Aug-18, Volume: 38, Issue:17 Topics: Adamantane; Amino Acid Sequence; Animals; Appetite Depressants; CHO Cells; Cricetinae; Humans; Indoles; Ligands; Magnetic Resonance Spectroscopy; Male; Meglumine; Molecular Sequence Data; Peptoids; Rats; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Spectrometry, Mass, Fast Atom Bombardment; Tetragastrin; Tryptophan	1995

Article

Year

Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands.

Journal of medicinal chemistry, 1995, Aug-18, Volume: 38, Issue:17

Topics: Adamantane; Amino Acid Sequence; Animals; Appetite Depressants; CHO Cells; Cricetinae; Humans; Indoles; Ligands; Magnetic Resonance Spectroscopy; Male; Meglumine; Molecular Sequence Data; Peptoids; Rats; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Spectrometry, Mass, Fast Atom Bombardment; Tetragastrin; Tryptophan

1995